- Professor Dan Grander, Experimental Oncology, Cancer Center, Karolinska Institute, Sweden
- Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden
- Division of Structural & Computational Biology, School of Biological Sciences, Nanyang Technical University, Singapore
- Kancera AB
- iNovacia AB
- Aprea AB
- Biomotif AB
Like us on Facebook
News
-
Fragment based ligand design of novel potent inhibitors of Tankyrases
16 May 2013
Sprint Bioscience’s collaborators at Nanyang Technological University in Singapore, have … Continue reading →
-
Structure of an important membrane protein solved
30 Apr 2013
The structure of an important membrane protein involved in metabolism … Continue reading →
-
Want to talk about cancer metabolism and autophagy?
28 Mar 2013
Cancer metabolism and autophagy is an emerging area generating a … Continue reading →
-
Sprint Bioscience to present at the Target Cancer Metabolism conference
18 Jan 2013
Sprint Bioscience will present at the Target Cancer Metabolism conference … Continue reading →
-
Publication by Sprint Bioscience’s chemistry team member selected for its important insights by SYNFACTS
27 Nov 2012
The editorial board of SYNFACTS, a journal that summarise … Continue reading →
-
New publications from Sprint Bioscience’s chemistry team members
9 Nov 2012
Two new articles have been published in Journal of Medicinal … Continue reading →
-
PRESS RELEASE
30 Oct 2012
TPP Global Development Ltd enters into a collaboration agreement with … Continue reading →
-
PRESS RELEASE
8 Oct 2012
SPRINT BIOSCIENCE STRENGTHENS ITS CANCER METABOLISM PORTFOLIO Sprint Bioscience, … Continue reading →
-
New Members to the Sprint Bioscience Team
18 Sep 2012
At Sprint Bioscience we are always aiming to grow our … Continue reading →
-
The new chemistry lab fully operational
2 Jun 2012
Sprint Biosciences chemistry lab in the new premises are now … Continue reading →
-
Fragment based ligand design of novel potent inhibitors of Tankyrases